Dr. Hymonti Dey, UiT The Arctic University of Norway, Norway
Dr. Hymonti Dey is an Associate Professor at UiT–The Arctic University of Norway, specializing in marine biotechnology and antimicrobial research. Originally from Bangladesh and now a Norwegian citizen, she earned her PhD in Natural Sciences in 2024, focusing on marine-derived peptide analogues against multi-resistant bacteria. With extensive research and teaching experience in microbiology, biochemistry, and marine bioactive compounds, Dr. Dey has contributed to interdisciplinary projects across Norway and abroad. Her work integrates laboratory innovation, mentorship, and collaborative science, reflecting her commitment to combating antimicrobial resistance through novel therapeutic development. 🌊🧫🔬
Publication Profile
Scopus
🎓 Education
Dr. Hymonti Dey holds a PhD in Natural Sciences (Marine Biotechnology) from UiT–The Arctic University of Norway (2019–2024), where she explored antimicrobial peptides of marine origin. She earned her MSc in Medical Biology from the University of Bergen (2014–2016), following an MSc and BSc in Biochemistry and Molecular Biology from the University of Dhaka (2005–2010). Her academic journey has spanned prestigious institutions in Bangladesh and Norway, equipping her with interdisciplinary expertise in biochemistry, molecular biology, and microbiology. This diverse academic background supports her advanced research in marine bioactive compounds and bacterial resistance. 📘🧬🧪
💼 Experience
Dr. Dey began her research career at icddr,b in Bangladesh, advancing from Senior Research Assistant to Research Officer in tuberculosis diagnostics and immunoassays. She continued as a Research Trainee at the University of Oslo, focusing on biofilm analysis and qPCR, before joining UiT as a PhD researcher. Her doctoral work centered on marine-derived antimicrobials and biosensor applications. Following her PhD, she worked as a Scientific Assistant and now serves as an Associate Professor at UiT, where she teaches biotechnology and microbiology, supervises theses, and leads lab-based instruction. She has also conducted external research stays in Oslo. 🧫📚👩🏫
🏆 Awards & Honors
Dr. Hymonti Dey has been recognized through prestigious roles and research opportunities, including her appointment as Associate Professor shortly after completing her PhD—a testament to her academic excellence and research contributions. She was involved in competitive UiT-funded projects such as LEADScAMR and AntifoMar and participated in international collaborations that expanded her expertise in antimicrobial innovation. Her supervision of Master’s theses and consistent teaching roles also reflect recognition by academic peers. With a Class B driving license, she maintains professional flexibility for collaborative and field research. 🥇📜🧠
🔬 Research Focus
Dr. Dey’s research focuses on the development and characterization of marine-derived antimicrobial peptides and peptidomimetics targeting multi-drug resistant bacteria. Her work spans bioactivity assays, antibiofilm testing, mode of action studies using bacterial biosensors, and engineering whole-cell biosensors. Key projects include LEADScAMR, AntifoMar, and biosensor development at UiT, which integrate microbiology, biotechnology, and natural product chemistry. Her multidisciplinary approach aims to discover and optimize novel scaffolds for combating antibiotic resistance. Through microscopy, PCR, MALDI-TOF, and flow cytometry, she advances bioanalytical strategies in therapeutic innovation. 🌐🧬🧫💡
Publication Top Notes
-
2022: “Synthesis and Antimicrobial Activity of Short Analogues of the Marine Antimicrobial Peptide Turgencin A” – Int J Mol Sci
-
2023: “Outer Membrane Integrity-Dependent Fluorescence of the Japanese Eel UnaG Protein in Live Escherichia coli Cells” – Biosensors
-
2023: “Investigation of Tetrasubstituted Heterocycles Reveals Hydantoins as a Promising Scaffold for Development of Novel Antimicrobials” – Eur J Med Chem
-
2022: “A Concise SAR-Analysis of Antimicrobial Cationic Amphipathic Barbiturates for an Improved Activity-Toxicity Profile” – Eur J Med Chem
-
2020: “NarAB Is an ABC-Type Transporter That Confers Resistance to Polyether Ionophores” – Front Microbiol
-
Under Review: “Antimicrobial Activity of Short Analogues of the Marine Peptide EeCentrocin 1” – Journal of Peptide Science
-
2015: “Longitudinal Immune Profiles in Type 1 Leprosy Reactions in Bangladesh, Brazil, Ethiopia and Nepal” – BMC Infect Dis
-
2013: “Feasibility of Using Non-Respiratory Specimens for Diagnosis of Child Tuberculosis” – Int J Tuberc Lung DisMDPIPubMedBioMed Central